Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Alex L. Zhang was 13 years old when he published a video game that went viral. More than 100,000 people bought the game for ...
4d
SpaceX buys AI coding startup Cursor for $60 billion in race for an edge over Anthropic and OpenAI
SpaceX will move forward with its $60 billion acquisition of artificial intelligence startup Cursor as Elon Musk’s space ...
States across the country are moving ahead with artificial intelligence regulations despite President Donald Trump's efforts ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
OpenAI has added a feature to its Codex macOS app that changes the barrier to AI-powered automation: instead of writing a prompt or configuring a workflow, a user performs a task while Codex watches, ...
Recursion Pharmaceuticals to update on FDA trial design for REC-4881 for FAP in the second half of 2026. Analysts expect potential upside from rare diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results